Taiwan FDA registration 8909b21a6b1d1da1ba27a52ac59fcd89
eBwell Blood Glucose Monitoring System
TW: 暐世舒適血糖測試儀套組
Taiwan·Risk Class 2·MD·Hsinchu General Factory of Weishi Biotechnology Co., Ltd·Registered Jun 30, 2017 – Jun 30, 2027ActiveRegistration details
- Analysis ID
- 8909b21a6b1d1da1ba27a52ac59fcd89
- License Form
- Ministry of Health Medical Device Manufacturing No. 005622
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Hsinchu General Factory of Weishi Biotechnology Co., Ltd
Product details
- Intended Use
- This product is designed for diabetics and healthcare professionals to measure blood glucose levels using whole blood collected at your fingertips. Performance Modification is as follows: This product is designed for diabetics and professionals, using whole blood collected at the fingertips to measure blood glucose concentration.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1345 Glucose Test System
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Jun 30, 2017
- Expiry Date
- Jun 30, 2027
About this record
Access comprehensive regulatory information for eBwell Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8909b21a6b1d1da1ba27a52ac59fcd89 and manufactured by Hsinchu General Factory of Weishi Biotechnology Co., Ltd. The authorized representative in Taiwan is Hsinchu General Factory of Weishi Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices